MAXILASE MAUX DE GORGE ALPHA-AMYLASE 3000 U. CEIP, coated tablet 15 tablets
Active ingredients: ALFA-AMYLASE
Commercialized according to BDPM
Coated tablet15 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MAXILASE MAUX DE GORGE ALPHA-AMYLASE 3000 U. CEIP, comprimé enrobé
- Pharmaceutical form
- comprimé enrobé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 15 comprimé(s)
- Marketing authorisation holder
- OPELLA HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 4 Sept 2013
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60095729CIP73993384CIP133400939933849Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALFA-AMYLASEcomprimé | 3000 U.CEIP · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.